Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.
about
History and current state of immunotherapy in glioma and brain metastasis.Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects.Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or gradeHuman cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.The oncomodulatory role of human cytomegalovirus in colorectal cancer: implications for clinical trials.The Viral Connection to Glioblastoma.MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a.High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers.Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects.Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients.The future of high-grade glioma: Where we are and where are we going.Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.Absence of human cytomegalovirus infection in childhood brain tumors.Prioritization schema for immunotherapy clinical trials in glioblastoma.A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.Cidofovir: a novel antitumor agent for glioblastoma.CMV infection and glioma, a highly controversial concept struggling in the clinical arenaTreatment of cytomegalovirus infections beyond acute disease to improve human health.Cytomegalovirus and glioma: putting the cart before the horse.Design and development of antivirals and intervention strategies against human herpesviruses using high-throughput approach.Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme.Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapyCytomegalovirus and glioblastoma; controversies and opportunities.Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes.Expanding role of cytomegalovirus as a human pathogen.Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.Decreased human leukocyte antigen A*02:01 frequency is associated with risk of glioma and existence of human cytomegalovirus: a case-control study in Northern China.Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization.O(6) -methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma.Novel vaccines for glioblastoma: clinical update and perspective.Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients.Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain.Expression of cytomegalovirus in glioblastoma multiforme: Myth or reality?Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study.Controversies in neuro-oncology: does valganciclovir have a role in the treatment of high-grade gliomas?Does valganciclovir have a role in glioblastoma therapy?Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience.Cytomegalovirus infection in brain tumors: A potential new target for therapy?Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells.
P2860
Q33656811-D059623E-E7F7-42ED-B545-57FBF8CE0D38Q33778830-90605976-AED5-4D86-8A8B-921DF7340E1BQ34277652-FB8F4061-5914-4F95-ABE5-A0D0316BEE2DQ34359722-2F9FD67C-5BB1-48B8-A84F-F65553A2E1FDQ34521746-752BD003-2884-4DB3-951A-755A9392F290Q34552036-0DA4B8AF-C58F-477F-9A31-08F15E9E7FD4Q34991006-2C0F8295-B830-4D1E-B7D5-C35CFEC89A68Q35028835-F764AC3F-D48D-4752-8AAF-8C60916E4A13Q35083935-81EE97AD-49ED-4E1C-B56E-DF524E61C0D3Q35092006-6C291163-B5EA-433C-811F-BCF2D013F215Q35114090-BF995E2E-44B0-4483-8C3E-D750CCF5214EQ35506920-8380B2E5-B03D-4F2D-9F88-0E9211419225Q36057137-676D8C33-28AF-46DF-8A2F-FD8734C4BD87Q37078999-EE2FA2C9-9630-4813-A2F4-C494847E454FQ37085029-A40381B4-8BCF-4AE6-AC73-6CFBC9DD3CEFQ37574749-8AD7A5B1-D5E0-4F79-8039-871552AE8101Q37580512-685C5A4D-A5EB-49AF-9771-918DE237FD33Q38176940-E95495D9-095A-46E1-97FA-2F31FA1CE750Q38218302-F8A4A2BA-38C1-40B5-84B9-C8BE626DEC7BQ38227257-84A1CAA6-18B6-40E0-82E4-2D9FE718EF10Q38262132-AE5DF81B-C216-4BB8-84A7-0750DB3927C6Q38288049-B19EDA5E-1C2B-436A-A145-DF00A7308EBCQ38355706-7EA82490-7028-48E9-A558-5D38DC8281F2Q38665860-FDDE2262-39C5-485D-9F7E-F373512EBE4BQ38673038-558426E7-4C1A-4B61-9CEE-DC023DEE6F82Q38703382-0A4DAB87-4A31-42FC-86D0-F69F48B04B69Q38775562-7648A2A3-1647-4244-9A09-CA235DE563FDQ38776409-D962D111-E34C-4603-A4EA-318D52F4883BQ38908320-916E72BA-F3DC-436D-AF4E-3E2C3B0FB73FQ39043417-5B528AC2-3BC9-48D3-86A9-140DECEAF757Q39279856-B278A6E0-5DD7-46AA-964E-0E748D393C5EQ40651359-536DCCBB-FB18-4522-BBCE-B5A1239746CFQ40707851-CCCC77E6-586C-4AF3-81AE-D3837D69F792Q40841407-9C0BC517-630D-4EDF-8517-860D7171783DQ40869992-FE4C7A1A-B81B-424A-B88F-D4EC387B7DA8Q41878293-96626BEB-B786-44F5-91A4-6DEC38B89361Q41950899-5DE8FBEF-81E0-400C-8AC1-E18E77E31DFEQ42180629-33C558BE-1D76-408F-931C-B9730BDC0E38Q42321647-8B47BD38-B1F1-4A30-9EB3-E46D140C6949Q42378308-6147CEF3-60DF-4D2A-AEC5-A340B5A8F8B6
P2860
Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of valganciclovir as a ...... , hypothesis-generating study.
@en
Effects of valganciclovir as a ...... , hypothesis-generating study.
@nl
type
label
Effects of valganciclovir as a ...... , hypothesis-generating study.
@en
Effects of valganciclovir as a ...... , hypothesis-generating study.
@nl
prefLabel
Effects of valganciclovir as a ...... , hypothesis-generating study.
@en
Effects of valganciclovir as a ...... , hypothesis-generating study.
@nl
P2093
P2860
P50
P356
P1476
Effects of valganciclovir as a ...... , hypothesis-generating study.
@en
P2093
Abiel Orrego
Anders Lilja
Birgitta Bjurman
Charlotte Tammik
Nina Wolmer Solberg
Petra Skarman
P2860
P304
P356
10.1002/IJC.28111
P577
2013-03-13T00:00:00Z